title: The muscarinic system, cognition and schizophrenia.
abstract: An increasing body of evidence has implicated the central muscarinic system as contributing to a number of symptoms of schizophrenia and serving as a potential target for pharmaceutical interventions. A theoretical review is presented that focuses on the central muscarinic system's contribution to the cognitive symptoms of schizophrenia. The aim is to bridge the void between pertinent neuropsychological and neurobiological research to provide an explanatory account of the role that the central muscarinic system plays in the symptoms of schizophrenia. First, there will be a brief overview of the relevant neuropsychological schizophrenia literature, followed by a concise introduction to the central muscarinic system. Subsequently, we will draw from animal, neuropsychological and pharmacological literature, and discuss the findings in relation to cognition, schizophrenia and the muscarinic system. Whilst unifying the multiple domains of research into a concise review will act as a useful line of enquiry into the central muscarinic systems contribution to the symptoms of schizophrenia, it will be made apparent that more research is needed in this field.
authors.affiliation: Brain and Psychological Sciences Research Centre (BPsyC), Faculty of Health, Arts, Design, Swinburne University of Technology, Melbourne 3122, VIC, Australia; Monash Alfred Psychiatry Research Centre (MAPrc), Monash University Central Clinical School and The Alfred Hospital, Melbourne 3004, VIC, Australia. Electronic address: scarruthers@swin.edu.au.
authors.forename: Sean P
authors.initials: SP
authors.lastname: Carruthers
authors.affiliation: Monash Alfred Psychiatry Research Centre (MAPrc), Monash University Central Clinical School and The Alfred Hospital, Melbourne 3004, VIC, Australia.
authors.forename: Caroline T
authors.initials: CT
authors.lastname: Gurvich
authors.affiliation: Brain and Psychological Sciences Research Centre (BPsyC), Faculty of Health, Arts, Design, Swinburne University of Technology, Melbourne 3122, VIC, Australia; Monash Alfred Psychiatry Research Centre (MAPrc), Monash University Central Clinical School and The Alfred Hospital, Melbourne 3004, VIC, Australia; Psychiatry, St Vincent's Hospital, Melbourne 3065, VIC, Australia.
authors.forename: Susan L
authors.initials: SL
authors.lastname: Rossell
mesh_terms: D000109:Acetylcholine / Q000502:physiology*; D000818:Animals; D001921:Brain / Q000503:physiopathology*; D018678:Cholinergic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003071:Cognition / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D011976:Receptors, Muscarinic / Q000502:physiology*; D012559:Schizophrenia / Q000188:drug therapy / Q000503:physiopathology*; D012565:Schizophrenic Psychology
chemical_list: D018678:Cholinergic Agents; D011976:Receptors, Muscarinic; D000109:Acetylcholine
keywords: Acetylcholine; Anti-muscarinic Syndrome; Anti-muscarinic psychosis; Attention; Cholinergic; Cognition; Executive functioning; Learning; M1 receptor; M4 receptor; Memory; Muscarinic; Psychosis; Schizophrenia; Xanomeline